GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (MEX:ABBV) » Definitions » NonCurrent Deferred Liabilities

AbbVie (MEX:ABBV) NonCurrent Deferred Liabilities : MXN54,129 Mil (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is AbbVie NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

AbbVie's non-current deferred liabilities for the quarter that ended in Sep. 2024 was MXN54,129 Mil.

AbbVie NonCurrent Deferred Liabilities Historical Data

The historical data trend for AbbVie's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie NonCurrent Deferred Liabilities Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21,311.80 72,526.23 61,726.63 42,696.24 33,133.73

AbbVie Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35,604.23 33,133.73 45,175.01 49,940.60 54,128.64

AbbVie NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of AbbVie's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie Business Description

Industry
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).